HK78897A - Antiviral combinations containing nucleoside analogs - Google Patents
Antiviral combinations containing nucleoside analogsInfo
- Publication number
- HK78897A HK78897A HK78897A HK78897A HK78897A HK 78897 A HK78897 A HK 78897A HK 78897 A HK78897 A HK 78897A HK 78897 A HK78897 A HK 78897A HK 78897 A HK78897 A HK 78897A
- Authority
- HK
- Hong Kong
- Prior art keywords
- nucleoside analogs
- combinations containing
- containing nucleoside
- antiviral combinations
- antiviral
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 239000002777 nucleoside Substances 0.000 title 1
- 150000003833 nucleoside derivatives Chemical class 0.000 title 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919110624A GB9110624D0 (en) | 1991-05-16 | 1991-05-16 | Combinations |
GB919121381A GB9121381D0 (en) | 1991-10-08 | 1991-10-08 | Combinations |
GB919123581A GB9123581D0 (en) | 1991-11-06 | 1991-11-06 | Combinations |
Publications (1)
Publication Number | Publication Date |
---|---|
HK78897A true HK78897A (en) | 1997-06-20 |
Family
ID=27265656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK78897A HK78897A (en) | 1991-05-16 | 1997-06-12 | Antiviral combinations containing nucleoside analogs |
Country Status (25)
Country | Link |
---|---|
US (2) | US5627186A (fr) |
EP (1) | EP0513917B2 (fr) |
JP (1) | JP2868671B2 (fr) |
KR (1) | KR100246687B1 (fr) |
CN (1) | CN1045961C (fr) |
AT (1) | ATE131730T1 (fr) |
AU (2) | AU1787492A (fr) |
CA (1) | CA2068790C (fr) |
CZ (1) | CZ285232B6 (fr) |
DE (2) | DE69206876T3 (fr) |
DK (1) | DK0513917T4 (fr) |
ES (1) | ES2083668T5 (fr) |
GR (1) | GR3018915T3 (fr) |
HK (1) | HK78897A (fr) |
IE (1) | IE73261B1 (fr) |
IL (1) | IL101883A (fr) |
LU (1) | LU90234I2 (fr) |
MX (1) | MX9202279A (fr) |
NL (1) | NL980018I2 (fr) |
NO (2) | NO301690B1 (fr) |
NZ (2) | NZ299240A (fr) |
OA (1) | OA10058A (fr) |
SK (1) | SK279262B6 (fr) |
TW (1) | TW273550B (fr) |
WO (1) | WO1992020344A1 (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9009861D0 (en) * | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
US6812233B1 (en) | 1991-03-06 | 2004-11-02 | Emory University | Therapeutic nucleosides |
GB9104740D0 (en) * | 1991-03-06 | 1991-04-17 | Wellcome Found | Antiviral nucleoside combination |
US6177435B1 (en) | 1992-05-13 | 2001-01-23 | Glaxo Wellcome Inc. | Therapeutic combinations |
AU4079593A (en) * | 1992-05-13 | 1993-12-13 | Wellcome Foundation Limited, The | Therapeutic combinations |
GB9215178D0 (en) * | 1992-07-16 | 1992-08-26 | Glaxo Group Ltd | Antiviral combinations |
IL113432A (en) | 1994-04-23 | 2000-11-21 | Glaxo Group Ltd | Process for the diastereoselective synthesis of nucleoside analogues |
FR2720397B1 (fr) * | 1994-05-24 | 1996-08-23 | Laphal Laboratoires Sa | Nouveaux oxathiolanes, leur procédé de préparation et les compositions pharmaceutiques qui en renferment. |
TW401303B (en) * | 1994-07-01 | 2000-08-11 | Janssen Pharmaceutica Nv | Anti-HIV triple combination |
GB9503850D0 (en) * | 1995-02-25 | 1995-04-19 | Glaxo Group Ltd | Medicaments |
MY115461A (en) * | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
PL330747A1 (en) | 1996-06-25 | 1999-05-24 | Glaxo Group Ltd | Vx478, zidovudin, ftc and/or 3tc containing combinations for use in treating hiv infections |
GB9622681D0 (en) * | 1996-10-31 | 1997-01-08 | Glaxo Group Ltd | Pharmaceutical compositions |
US6113920A (en) * | 1996-10-31 | 2000-09-05 | Glaxo Wellcome Inc. | Pharmaceutical compositions |
TW536403B (en) * | 1997-03-24 | 2003-06-11 | Glaxo Group Ltd | An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy |
DE69840216D1 (de) | 1997-08-08 | 2008-12-24 | Celmed Oncology Usa Inc | Verfahren und Zubereitungen um Resistenz gegen biologische oder chemische Therapien zu Überwinden |
US6245750B1 (en) | 1998-01-23 | 2001-06-12 | Newbiotics, Inc. | Enzyme catalyzed therapeutic agents |
US7462605B2 (en) | 1998-01-23 | 2008-12-09 | Celmed Oncology (Usa), Inc. | Phosphoramidate compounds and methods of use |
BR9911457A (pt) * | 1998-06-24 | 2001-12-11 | Univ Emory | Uso de 3'-azida-2', 3'-dideoxiuridina em combinaçãocom drogas anti-hiv adicionais para a manufaturade um medicamento para o tratamento de hiv |
IL147749A0 (en) | 1999-07-22 | 2002-08-14 | Newbiotics Inc | Methods for treating therapy-resistant tumors |
US6432966B2 (en) | 1999-10-29 | 2002-08-13 | Smithkline Beecham Corporation | Antiviral combinations |
AP2220A (en) * | 2001-05-11 | 2011-03-24 | Cipla Medpro Pty Ltd | Pharmaceutical composition. |
US20050287177A1 (en) * | 2002-11-08 | 2005-12-29 | Glaxo Group Unlimited And Smithkline Beecham Corp. | Pharmaceutical compositions |
WO2004064846A1 (fr) | 2003-01-14 | 2004-08-05 | Gilead Sciences, Inc. | Compositions et methodes de polytherapie antivirale |
US7662852B2 (en) | 2003-05-22 | 2010-02-16 | Lead Chemical Co., Ltd. | Compounds and preparations having antiviral effect |
TWI375560B (en) | 2005-06-13 | 2012-11-01 | Gilead Sciences Inc | Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same |
TWI471145B (zh) | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
EP1975923B1 (fr) * | 2007-03-28 | 2016-04-27 | Nuance Communications, Inc. | Reconnaissance vocale non-native plurilingues |
WO2010137027A1 (fr) | 2009-05-27 | 2010-12-02 | Hetero Research Foundation | Formes pharmaceutiques solides de lamivudine s'administrant par voie orale |
CN114010776A (zh) | 2010-06-09 | 2022-02-08 | 疫苗技术股份有限公司 | 用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫 |
JP2015509524A (ja) | 2012-03-05 | 2015-03-30 | シプラ・リミテッド | ラミブジン、フェスティナビルおよびネビラピンを含んでなる抗レトロウイルス医薬組成物 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1214611B (it) * | 1985-05-22 | 1990-01-18 | Schiena Ricerche | Composti per uso cosmetico dermatologico e relative composizioni. |
GB8717955D0 (en) * | 1987-07-29 | 1987-09-03 | Fujisawa Pharmaceutical Co | Prevention & treatment of aids |
US5270464A (en) * | 1989-03-14 | 1993-12-14 | Janssen Pharmaceutica N.V. | Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones |
WO1989009056A1 (fr) * | 1988-03-23 | 1989-10-05 | New York University | Composition antivirale contenant des diones aromatiques polycycliques et des analogues de nucleosides, et procede de traitement d'infections retrovirales |
JPH02504283A (ja) * | 1988-03-23 | 1990-12-06 | ニューヨーク ユニバーシィティ | 芳香族多環式ジオン化合物とヌクレオシド類似化合物とを含む抗ウイルス性組成物及びレトロウイルス感染を治療するための方法 |
US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
JPH02142733A (ja) * | 1988-09-28 | 1990-05-31 | Sigma Tau Ind Farmaceut Riunite Spa | ジドブジン含有エイズ治療剤 |
EP0374096B1 (fr) * | 1988-12-14 | 1992-12-02 | Ciba-Geigy Ag | Thérapie combinée utilisant le 2',5'-didéoxypurine nucléoside et inhibiteur de purine nucléoside-phosphorylase et ses compositions |
US5132291A (en) * | 1989-01-24 | 1992-07-21 | Gensia Pharmaceuticals, Inc. | Antivirals and methods for increasing the antiviral activity of azt |
IL93136A (en) * | 1989-02-23 | 1995-01-24 | Janssen Pharmaceutica Nv | History of tetrahydroimidazo [1,4] benzodiazepine-2-thione, their preparation and pharmaceutical preparations containing them |
NZ232912A (en) * | 1989-03-17 | 1992-06-25 | Oncogen Ltd Lp | Synergistic composition of nucleoside derivatives for inhibiting hiv |
US5011829A (en) * | 1989-06-02 | 1991-04-30 | G. D. Searle & Co. | Pharmaceutical composition and method of inhibiting virus |
SE464168B (sv) † | 1989-07-19 | 1991-03-18 | Bo Fredrik Oeberg | Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt) |
US5116823A (en) * | 1990-02-27 | 1992-05-26 | Roger Williams General Hospital | Drug combinations containing AZT |
GB9009861D0 (en) * | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
GB9104740D0 (en) * | 1991-03-06 | 1991-04-17 | Wellcome Found | Antiviral nucleoside combination |
-
1992
- 1992-05-11 AU AU17874/92A patent/AU1787492A/en not_active Abandoned
- 1992-05-11 CZ CZ932428A patent/CZ285232B6/cs not_active IP Right Cessation
- 1992-05-11 DE DE69206876T patent/DE69206876T3/de not_active Expired - Lifetime
- 1992-05-11 DE DE1998175016 patent/DE19875016I2/de active Active
- 1992-05-11 EP EP92201328A patent/EP0513917B2/fr not_active Expired - Lifetime
- 1992-05-11 WO PCT/EP1992/001106 patent/WO1992020344A1/fr active IP Right Grant
- 1992-05-11 ES ES92201328T patent/ES2083668T5/es not_active Expired - Lifetime
- 1992-05-11 DK DK92201328T patent/DK0513917T4/da active
- 1992-05-11 AT AT92201328T patent/ATE131730T1/de active
- 1992-05-11 SK SK1199-93A patent/SK279262B6/sk not_active IP Right Cessation
- 1992-05-15 JP JP4148384A patent/JP2868671B2/ja not_active Expired - Lifetime
- 1992-05-15 MX MX9202279A patent/MX9202279A/es not_active IP Right Cessation
- 1992-05-15 NO NO921947A patent/NO301690B1/no not_active IP Right Cessation
- 1992-05-15 NZ NZ299240A patent/NZ299240A/en not_active IP Right Cessation
- 1992-05-15 CN CN92104553A patent/CN1045961C/zh not_active Expired - Lifetime
- 1992-05-15 NZ NZ242754A patent/NZ242754A/en not_active IP Right Cessation
- 1992-05-15 IL IL10188392A patent/IL101883A/en not_active IP Right Cessation
- 1992-05-15 AU AU16279/92A patent/AU661307B2/en not_active Expired
- 1992-05-15 KR KR1019920008239A patent/KR100246687B1/ko not_active IP Right Cessation
- 1992-05-15 TW TW081103780A patent/TW273550B/zh not_active IP Right Cessation
- 1992-05-15 CA CA002068790A patent/CA2068790C/fr not_active Expired - Lifetime
- 1992-07-01 IE IE921566A patent/IE73261B1/en not_active IP Right Cessation
-
1993
- 1993-10-22 OA OA60427A patent/OA10058A/en unknown
-
1994
- 1994-03-28 US US08/219,176 patent/US5627186A/en not_active Expired - Lifetime
-
1996
- 1996-02-07 GR GR960400321T patent/GR3018915T3/el unknown
- 1996-02-22 US US08/605,610 patent/US5859021A/en not_active Expired - Lifetime
-
1997
- 1997-06-12 HK HK78897A patent/HK78897A/xx not_active IP Right Cessation
-
1998
- 1998-04-24 LU LU90234C patent/LU90234I2/fr unknown
- 1998-04-28 NL NL980018C patent/NL980018I2/nl unknown
-
1999
- 1999-07-22 NO NO1999018C patent/NO1999018I1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK78897A (en) | Antiviral combinations containing nucleoside analogs | |
KR0156747B1 (en) | Use of 1,3-oxathiolan nucleoside analogues in the treatment of hepatitis-b | |
GR3026218T3 (en) | Antiviral 4-substituted-2-deoxy-2,3-didehydro derivatives of alpha D-neuraminic acid | |
IL101144A0 (en) | Pharmaceutical compositions containing 1,3-oxathiolane nucleoside analogue and derivatives thereof for the treatment of hepatitis b virus infections | |
EP0656778A4 (fr) | NUCLEOSIDES ENANTIOMERIQUEMENT PURS DE -g(b)-D-DIOXOLANE. | |
GB8822546D0 (en) | Antiviral combinations | |
IL93594A0 (en) | Pharmaceutical compositions containing an imidazopyrimidone derivative | |
ZA898926B (en) | Antiviral compounds | |
DK0728002T3 (da) | Anvendelse af 2-aminopurinderivater til behandling og forebyggelse af humant herpesvirus 7-infektioner | |
DK0728001T3 (da) | Anvendelse af 2-aminopurinderivater til behandling og forebyggelse af humant herpesvirus 6-infektioner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20120510 |